Breast Cancer Trial, By Invitation NCT06834204 Sponsor: Rutgers, The State University of New Jersey Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06834204
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed in the past 6 months with one of these cancers at Stage I, II, or III: breast cancer, prostate cancer, urinary bladder cancer, or endometrial cancer
  • People whose cancer treatment has the goal of curing the cancer (rather than just managing it)
  • People who had their first visit at the cancer centre within the last 3 months
  • People receiving curative-intent cancer treatment at the Rutgers Cancer Institute of New Jersey
  • People who had at least one of the following health conditions before their cancer diagnosis that requires medication to manage: high blood pressure, high cholesterol, or type 2 diabetes
  • People who are currently receiving care from a primary care doctor or provider
  • People who speak English or Spanish

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a heart attack or stroke within the past year
  • People who have heart failure where the heart is pumping at less than 30% of its normal capacity
  • People who have moderate-to-severe chronic kidney disease (specifically stage IV or V, meaning the kidneys are working at less than 30% of normal function)
  • People who do not speak English or Spanish

Note: People whose cancer spreads to other parts of the body during the 18-month trial period may still be allowed to continue participating, unless they choose to withdraw.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 3 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Rutgers, The State University of New Jersey
Registry
ClinicalTrials.gov
Start date
24 April 2026
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Connected Care-Continuity with Primary Care Provider

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 3 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov